Overview

The VALIDATE-D Study

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether vitamin D receptor agonist therapy lowers renin-angiotensin system activity.
Phase:
N/A
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Calcitriol
Dihydroxycholecalciferols
Lisinopril